Fortive Corp Quarterly Earnings Per Share, Diluted in USD/shares from Q3 2015 to Q3 2024

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary: Fortive Corp quarterly/annual Earnings Per Share, Diluted history and growth rate from Q3 2015 to Q3 2024.
Fortive Corp Earnings Per Share, Diluted for the quarter ending September 27, 2024 was 0.63 USD/shares, a 3.28% increase year-over-year.
Fortive Corp Earnings Per Share, Diluted for the twelve months ending September 27, 2024 was 2.5 USD/shares, a 7.3% increase year-over-year.
Fortive Corp annual Earnings Per Share, Diluted for 2023 was 2.43 USD/shares, a 15.7% increase from 2022.
Fortive Corp annual Earnings Per Share, Diluted for 2022 was 2.1 USD/shares, a 28.8% increase from 2021.
Fortive Corp annual Earnings Per Share, Diluted for 2021 was 1.63 USD/shares, a 63.7% decline from 2020.

Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)

Earnings Per Share, Diluted, Quarterly (USD/shares)

Earnings Per Share, Diluted, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$2.50	$0.63	+$0.02	+3.28%	Jun 29, 2024	Sep 27, 2024	10-Q	2024-10-30
Q2 2024	$2.48	$0.55	$0	-6.78%	Mar 30, 2024	Jun 28, 2024	10-Q	2024-07-24
Q1 2024	$2.52	$0.58	+$0.09	+18.4%	Jan 1, 2024	Mar 29, 2024	10-Q	2024-04-24
Q4 2023	$2.43	$0.74	+$0.10	+15.6%	Sep 30, 2023	Dec 31, 2023	10-K	2024-02-27
Q3 2023	$2.33	$0.61	+$0.08	+15.1%	Jul 1, 2023	Sep 29, 2023	10-Q	2024-10-30
Q2 2023	$2.25	$0.59	+$0.11	+22.9%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-07-24
Q1 2023	$2.14	$0.49	+$0.04	+8.89%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-04-24
Q4 2022	$2.10	$0.64	+$0.20	+45.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-27
Q3 2022	$1.90	$0.53	+$0.11	+26.2%	Jul 2, 2022	Sep 30, 2022	10-Q	2023-10-25
Q2 2022	$1.79	$0.48	$0	0%	Apr 2, 2022	Jul 1, 2022	10-Q	2023-07-26
Q1 2022	$1.79	$0.45	+$0.18	+66.7%	Jan 1, 2022	Apr 1, 2022	10-Q	2023-04-26
Q4 2021	$1.61	$0.44	-$3	-86.9%	Oct 2, 2021	Dec 31, 2021	10-K	2022-03-01
Q3 2021	$4.54	$0.42	$0	-31.1%	Jul 3, 2021	Oct 1, 2021	10-Q	2022-10-26
Q2 2021	$4.73	$0.48	+$0.15	+45.5%	Apr 3, 2021	Jul 2, 2021	10-Q	2022-07-28
Q1 2021	$4.58	$0.27	+$0.20	+286%	Jan 1, 2021	Apr 2, 2021	10-Q	2022-04-28
Q4 2020	$4.38	$3.37	+$2.85	+548%	Sep 26, 2020	Dec 31, 2020	10-K	2022-03-01
Q3 2020	$1.53	$0.61	+$0.05	+8.93%	Jun 27, 2020	Sep 25, 2020	10-K	2022-03-01
Q2 2020	$1.48	$0.33	$0	-28.3%	Mar 28, 2020	Jun 26, 2020	10-K	2022-03-01
Q1 2020	$1.61	$0.07	$0	-83.7%	Jan 1, 2020	Mar 27, 2020	10-K	2022-03-01
Q4 2019	$1.97	$0.52	-$6	-91.6%	Sep 28, 2019	Dec 31, 2019	10-K	2021-02-26
Q3 2019	$7.62	$0.56	$0	-12.5%	Jun 29, 2019	Sep 27, 2019	10-K	2021-02-26
Q2 2019	$7.70	$0.46	$0	-44.6%	Mar 30, 2019	Jun 28, 2019	10-K	2021-02-26
Q1 2019	$8.07	$0.43	$0	-41.9%	Jan 1, 2019	Mar 29, 2019	10-K	2021-02-26
Q4 2018	$8.38	$6.17	+$5.22	+549%	Sep 29, 2018	Dec 31, 2018	10-K	2020-02-27
Q3 2018	$3.16	$0.64	$0	-15.8%	Jun 30, 2018	Sep 28, 2018	10-K	2020-02-27
Q2 2018	$3.28	$0.83	+$0.15	+22.1%	Mar 31, 2018	Jun 29, 2018	10-K	2020-02-27
Q1 2018	$3.13	$0.74	+$0.17	+29.8%	Jan 1, 2018	Mar 30, 2018	10-K	2020-02-27
Q4 2017	$2.96	$0.95	+$0.31	+48.4%	Sep 30, 2017	Dec 31, 2017	10-K	2019-02-28
Q3 2017	$2.65	$0.76	+$0.11	+16.9%	Jul 1, 2017	Sep 29, 2017	10-K	2019-02-28
Q2 2017	$2.54	$0.68	$0	-1.45%	Apr 1, 2017	Jun 30, 2017	10-K	2019-02-28
Q1 2017	$2.55	$0.57	+$0.04	+7.55%	Jan 1, 2017	Mar 31, 2017	10-K	2019-02-28
Q4 2016	$2.51	$0.64			Oct 1, 2016	Dec 31, 2016	10-K	2018-02-28
Q3 2016		$0.65	+$0.08	+14%	Jul 2, 2016	Sep 30, 2016	10-K	2018-02-28
Q2 2016		$0.69			Apr 2, 2016	Jul 1, 2016	10-K	2018-02-28
Q1 2016		$0.53			Jan 1, 2016	Apr 1, 2016	10-K	2018-02-28
Q3 2015		$0.57			Jul 4, 2015	Oct 2, 2015	10-Q	2016-10-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.